Adaptin Bio (APTN) Total Debt (2022 - 2026)

Adaptin Bio has disclosed Total Debt across 4 years of filings, most recently posting $162208.0 for Q2 2026.

• In Q2 2026, Total Debt changed N/A year-over-year to $162208.0; the TTM figure through Jun 2026 stood at $162208.0 (changed N/A YoY), while the FY2024 annual figure was $1.8 million, up 1004.22% from the prior year.
• Total Debt came in at $162208.0 for Q2 2026 at Adaptin Bio, down from $240698.0 in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.8 million in Q4 2024 to a low of $5304.0 in Q4 2022.
• Average Total Debt over 4 years is $319773.2, with a median of $162438.0 recorded in 2023.
• Year-over-year, Total Debt surged 2962.56% in 2023 and surged 303.05% in 2024.
• Over 4 years, Total Debt stood at $5304.0 in 2022, then surged by 2962.56% to $162438.0 in 2023, then jumped by 1004.22% to $1.8 million in 2024, then tumbled by 90.96% to $162208.0 in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $162208.0 in Q2 2026, $240698.0 in Q1 2026, and $1.8 million in Q4 2024.